socalTECH

APRIL 20, 2017

Thousand Oaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Riverbed said it will continue to offer up Xirrus as a stand-alone enterprise WLAN solution. Financial terms of the acquisition were not announced.

Thousand Oaks 127

Thousand Oaks Acquisition Startup Networking 127

socalTECH

JANUARY 27, 2020

Kobe Bryant , the basketball legend who also was one half of Los Angeles private equity investment firm Bryant Stibel , is dead at the age of 41, after a tragic helicopter crash in Calabasas took his life, the life of one of his daughters, and seven others. READ MORE>>.

Thousand Oaks 113

Thousand Oaks Legalzoom Calabasas High Tech 113

socalTECH

NOVEMBER 7, 2013

Thousand Oaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group.

Thousand Oaks 164

Thousand Oaks UCLA Venture Capital Equity 164

socalTECH

OCTOBER 29, 2015

We sat down with Brett Crosby (who founded Urchin Software, the company which became Google Analytics) and Brew Johnson , the co-founders of the company, to learn more about the company and what it's working on. Thanks for the time today, it's great to get a chance to talk with you about your company.

Southern California 100

Southern California Google Technical Review Manhattan Beach 100

Xconomy

JULY 22, 2016

The top news in biotech this week centers around one big job opening: the head seat at Biogen, now that George Scangos has announced plans to leave the company. Who takes the gig, and the strategic direction he or she chooses for Biogen will have implications not just for the company and its employees, but the sector overall.

Startup 40

Startup San Diego News Thousand Oaks 40

Xconomy

JUNE 10, 2016

The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. As the conference wrapped up, a Morgan Stanley analyst noted that Pfizer the previous week had raised its drug prices nine percent, continuing a regular pattern of price increases. .

Incubator 67

Incubator Thousand Oaks Screening Pricing 67